These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21297299)

  • 1. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
    Uchida T; Kanazawa T; Takashima Y; Okada H
    Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects on atopic dermatitis by anti-RelA short interfering RNA combined with functional peptides Tat and AT1002.
    Uchida T; Kanazawa T; Kawai M; Takashima Y; Okada H
    J Pharmacol Exp Ther; 2011 Aug; 338(2):443-50. PubMed ID: 21531792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Liquid Crystal Formulation that Can Penetrate the Stratum Corneum for Intradermal Delivery of Small Interfering RNA.
    Kawai M; Ibaraki H; Takashima Y; Kanazawa T; Okada H
    Mol Pharm; 2021 Mar; 18(3):1038-1047. PubMed ID: 33395310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide.
    Ibaraki H; Kanazawa T; Takashima Y; Okada H; Seta Y
    Molecules; 2016 Sep; 21(10):. PubMed ID: 27669207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal anti-nuclear kappaB siRNA therapy for atopic dermatitis using a combination of two kinds of functional oligopeptide.
    Ibaraki H; Kanazawa T; Takashima Y; Okada H; Seta Y
    Int J Pharm; 2018 May; 542(1-2):213-220. PubMed ID: 29551748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-RelA siRNA-Encapsulated Flexible Liposome with Tight Junction-Opening Peptide as a Non-invasive Topical Therapeutic for Atopic Dermatitis.
    Ibaraki H; Kanazawa T; Kurano T; Oogi C; Takashima Y; Seta Y
    Biol Pharm Bull; 2019; 42(7):1216-1225. PubMed ID: 31257297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming thickened pathological skin in psoriasis via iontophoresis combined with tight junction-opening peptide AT1002 for intradermal delivery of NF-κB decoy oligodeoxynucleotide.
    Fukuta T; Tanaka D; Inoue S; Michiue K; Kogure K
    Int J Pharm; 2021 Jun; 602():120601. PubMed ID: 33905867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of AT1002 on the delivery of ritonavir in the presence of bioadhesive polymer, carrageenan.
    Song KH; Eddington ND
    Arch Pharm Res; 2012 May; 35(5):937-43. PubMed ID: 22644862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.
    Kanazawa T; Akiyama F; Kakizaki S; Takashima Y; Seta Y
    Biomaterials; 2013 Dec; 34(36):9220-6. PubMed ID: 23992922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
    Song KH; Fasano A; Eddington ND
    Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery.
    Song KH; Kim SB; Shim CK; Chung SJ; Kim DD; Rhee SK; Choi GJ; Kim CH; Kim K
    Drug Des Devel Ther; 2015; 9():1815-23. PubMed ID: 25848218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple, noninvasive and efficient method for transdermal delivery of siRNA.
    Lin CM; Huang K; Zeng Y; Chen XC; Wang S; Li Y
    Arch Dermatol Res; 2012 Mar; 304(2):139-44. PubMed ID: 22009459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting neuronal nitric oxide synthase by a cell penetrating peptide Tat-LK15/siRNA bioconjugate.
    Peng J; Rao Y; Yang X; Jia J; Wu Y; Lu J; Tao Y; Tu W
    Neurosci Lett; 2017 May; 650():153-160. PubMed ID: 28450191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress in transdermal delivery for small interfering RNA].
    Chen Y; Xu N; Hu Z
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):622-631. PubMed ID: 32347057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide.
    Wei B; Wei Y; Zhang K; Wang J; Xu R; Zhan S; Lin G; Wang W; Liu M; Wang L; Zhang R; Li J
    Biomed Pharmacother; 2009 May; 63(4):313-8. PubMed ID: 18823738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
    Motlekar NA; Fasano A; Wachtel MS; Youan BB
    J Drug Target; 2006 Jun; 14(5):321-9. PubMed ID: 16882552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical delivery of siRNA into skin using SPACE-peptide carriers.
    Chen M; Zakrewsky M; Gupta V; Anselmo AC; Slee DH; Muraski JA; Mitragotri S
    J Control Release; 2014 Apr; 179():33-41. PubMed ID: 24434423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models.
    Lee WR; Shen SC; Sung CT; Liu PY; Fang JY
    Pharm Res; 2018 Apr; 35(7):128. PubMed ID: 29700662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
    Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
    J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment.
    Boakye CHA; Patel K; Doddapaneni R; Bagde A; Marepally S; Singh M
    J Control Release; 2017 Jan; 246():120-132. PubMed ID: 27170227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.